- Profile
- Personal Information
- Publications
Experts in Ophthalmology
Rando Allikmets PAN Shilie YANG Zhihua Xin Zhang Mohamed Abou Shousha Chrisfouad R. Alabiad Thomas Albini Eduardo Alfonso Jane Koretz Guillermo Amescua Richard M. Awdeh James Banta Audina M. Berrocal Byoung Seung Ham Hilda Capo Manjusha Rajagopala Kara M. Cavuoto Ta Chen P. Chang Victoria Chang Esen K Akpek View MoreStefan Sperl is co-founder and COO of Panoptes Pharma. Prior to this position he was global Project Manager at Nabriva Therapeutics AG, responsible for all development programs ranging from early preclinical to clinical phase 2 programs. Before that he headed the project management at Biovertis AG and was responsible for the internal and external drug discovery programs with emphasis on structure-based hit-to-lead optimizations. From 2000 to 2005, Dr. Sperl headed the small molecule research unit at Wilex AG, where he was responsible for lead optimization and GMP production. He has invented several patents of small molecules currently in clinical development. Dr. Stefan Sperl received his PhD in Chemistry from the Max Planck Institute in Martinsried, Germany in 2000.
Opthalmology